StrataGent Life Sciences

About:

StrataGent Life Sciences is a specialty drug therapy company developing painless and non-invasive therapies for various diseases. 

Website: https://www.stratagentlifesciences.com

Top Investors: Essex Woodlands Healthcare Partners, Aphelion Capital, Quantum Technology Partners

Description:

StrataGent Life Sciences, Inc. is a specialty drug therapy company developing painless, non-invasive versions of therapies that would otherwise be injected. Its products are based on its proprietary microjet technology, which delivers large and small therapeutic molecules without a device penetrating into or through the skin. In May of 2004, StrataGent received a $2 million award from the Advanced Technology Program (ATP) at the National Institute of Standards and Technology to support the development of the StrataGent microjet technology.